Medicus Pharma Ltd. (MDCX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Raza Bokhari M.B.A., M.D., MBA | CEO & Executive Chairman | -- | -- | 1968 |
| Mr. James P. Quinlan C.P.A. | Chief Financial Officer | 443.27k | -- | 1965 |
| Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D. | Chief Scientific Officer and Head of R&D Program | 450.71k | -- | 1961 |
| Ms. Carolyn Bonner | President | -- | -- | 1985 |
| Ms. Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations | -- | -- | -- |
| Ms. Viktoriia Slepeniuk | Senior Vice President of Public Relations | -- | -- | -- |
| Ms. Maryann Adesso | Chief of Staff | -- | -- | -- |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer | -- | -- | 1975 |
Medicus Pharma Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
Description
Medicus Pharma Ltd., a biotech/life sciences company, focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops SkinJect, with an indication for basal cell carcinoma that is drug device combination product using novel dissolvable microneedle arrays for the treatment of non-melanoma skin cancers. The company was founded in 2015 and is headquartered in Toronto, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 28, 2025 at 12:00 AM UTC
253G2: Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular
April 4, 2025 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
March 28, 2025 at 12:00 AM UTC
253G2: Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular